Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy-updated results from an expanded access programme

被引：0

作者：

Petruzelka, L. ^{[1
]}

Zimovjanova, M. ^{[1
]}

Konopasek, B. ^{[1
]}

Mares, P. ^{[1
]}

Dlouha, Z. ^{[1
]}

机构：

[1] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic

来源：

ANNALS OF ONCOLOGY | 2004年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：36 / 36

页数：1

共 50 条

[21] Fulvestrant in the management of postmenopausal women with advanced, endocrine-responsive breast cancer [J].

Oakman, Catherine ;

Moretti, Erica ;

Santarpia, Libero ;

Di Leo, Angelo .

FUTURE ONCOLOGY, 2011, 7 (02) :173-186

[22] Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results [J].

Loibl, Sibylle ;

Turner, Nicholas C. ;

Ro, Jungsil ;

Cristofanilli, Massimo ;

Iwata, Hiroji ;

Im, Seock-Ah ;

Masuda, Norikazu ;

Loi, Sherene ;

Andre, Fabrice ;

Harbeck, Nadia ;

Verma, Sunil ;

Folkerd, Elizabeth ;

Theall, Kathy Puyana ;

Hoffman, Justin ;

Zhang, Ke ;

Bartlett, Cynthia Huang ;

Dowsett, Mitchell .

ONCOLOGIST, 2017, 22 (09) :1028-1038

[23] Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series [J].

Luigi Di Lauro ;

Patrizia Vici ;

Maddalena Barba ;

Laura Pizzuti ;

Domenico Sergi ;

Massimo Rinaldi ;

Anna Di Benedetto ;

Isabella Sperduti ;

Abeer M. Shaaban ;

Valerie Speirs ;

Marcella Mottolese ;

Ruggero De Maria ;

Marcello Maugeri-Saccà .

Breast Cancer Research and Treatment, 2014, 148 :73-80

[24] Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series [J].

Di Lauro, Luigi ;

Vici, Patrizia ;

Barba, Maddalena ;

Pizzuti, Laura ;

Sergi, Domenico ;

Rinaldi, Massimo ;

Di Benedetto, Anna ;

Sperduti, Isabella ;

Shaaban, Abeer M. ;

Speirs, Valerie ;

Mottolese, Marcella ;

De Maria, Ruggero ;

Maugeri-Sacca, Marcello .

BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (01) :73-80

[25] Lapatinib as salvage therapy in metastatic breast cancer: Preliminary results from an expanded access program [J].

Giotta, F. ;

Latorre, A. ;

Monticelli, G. ;

Oliva, S. ;

Albano, D. ;

Colucci, G. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[26] Endocrine therapy for the treatment of postmenopausal women with breast cancer [J].

Harichand-Herdt, Seema ;

Zelnak, Amelia ;

O'Regan, Ruth .

EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (02) :187-198

[27] ADHERENCE TO ENDOCRINE THERAPY IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER [J].

Bauer, T. ;

Ziller, M. ;

Holzhauer, W. ;

Ziller, V. ;

Wagner, U. ;

Hadji, P. .

ANTICANCER RESEARCH, 2008, 28 (6B) :4063-4063

[28] Fulvestrant (Faslodex) in women with metastatic breast cancer after progression on prior anti-estrogenic therapy [J].

Di Bitonto, Pasqualina ;

Abate, Antonio ;

Vessia, Giacomo ;

De Lena, Mario .

ANNALS OF ONCOLOGY, 2007, 18 :49-49

[29] Fulvestrant in pretreated postmenopausal patients with metastatic breast cancer: analysis from the French multicentre compassionate use programme [J].

Gligorov, J. ;

Antoine, E. C. ;

Dalenc, F. ;

Namer, M. ;

Chollet, P. ;

Spielmann, M. ;

Campone, M. ;

Zelek, L. ;

Debled, M. .

BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 :S116-S116

[30] ECONOMIC EVALUATION AND BUDGET IMPACT OF FULVESTRANT (FASLODEX®) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE NOT RECEIVED PRIOR ENDOCRINE THERAPY FROM THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM IN MEXICO [J].

Carlos, F. ;

Guzman, J. ;

Naranjo, M. ;

Carmona, M. .

VALUE IN HEALTH, 2019, 22 :S81-S81

← 1 2 3 4 5 →